DaVita HealthCare Partners Inc (DVA)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $10.96B
Last updated: Nov 17, 2026 at 4:23 PM ET
DaVita HealthCare Partners Inc (DVA) Statistics
DaVita HealthCare Partners (DVA) has a market cap of $10.96B and an enterprise value of $21.23B. Its share count is down 11.43% from a year earlier. Its net debt of $10.27B equals 93.75% of its market cap.
Total Valuation
Enterprise value is 93.75% above the market cap, as debt exceeds cash.
| Market Cap | $10.96B |
|---|---|
| Enterprise Value | $21.23B |
| Latest price (Nov 17, 2026) | $172.97 |
Key Dates
The next earnings report is expected on Feb 1, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 1, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 29, 2026 |
| Fiscal Year End | December |
Valuation Ratios
The price to sales ratio is 0.8x. Its year-end P/E ranged from 10.5x to 21.0x from 2016 to 2025.
| P/E Ratio | 12.3x |
|---|---|
| Forward P/E | 11.7x |
| P/S Ratio | 0.8x |
| Forward P/S | 0.8x |
| P/FCF Ratio | 8.5x |
| P/OCF Ratio | 5.9x |
| PEG Ratio | 0.5 |
Enterprise Valuation
Counting debt and cash, the company is valued at 7.6x EBITDA and 16.5x free cash flow.
| EV / Earnings | 17.4x |
|---|---|
| EV / Sales | 1.5x |
| EV / EBITDA | 7.6x |
| EV / EBIT | 10.0x |
| EV / FCF | 16.5x |
Price Statistics
The stock is up 42.30% over 52 weeks and trades 5.13% below its 50-day average.
| Beta (1Y) | -0.06 |
|---|---|
| 52-Week Change | +42.30% |
| 1-Month Change | -7.50% |
| 3-Month Change | -2.43% |
| 6-Month Change | -11.12% |
| 5-Year Change | +81.62% |
| 10-Year Change | +219.86% |
| Total Return (1Y) | +42.30% |
| Total Return (3Y CAGR) | +21.61% |
| Total Return (5Y CAGR) | +11.22% |
| Return vs SPY (1Y) | +36.84% |
| Max Drawdown (1Y) | -28.22% |
| Max Drawdown (3Y) | -41.43% |
| Sharpe Ratio (1Y) | 0.87 |
| Correlation with SPY (1Y) | -0.02 |
| 50-Day Average | $182.32 |
| 200-Day Average | $181.54 |
| 52-Week Range | $101.00 to $247.49 |
| RSI (14 Days) | 40.8 |
| Average Volume (20 Days) | 846.16K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.41x current liabilities.
| Current Ratio | 1.41x |
|---|---|
| Quick Ratio | 1.36x |
| Debt / EBITDA | 3.82x |
| Debt / FCF | 8.32x |
| Interest Coverage | 3.51x |
Returns and Efficiency
Return on invested capital is 16.40% over the last 12 months, against a 5-year average of 14.50%.
| Return on Assets (ROA) | 6.84% |
|---|---|
| Return on Invested Capital (ROIC) | 16.40% |
| Return on Capital Employed (ROCE) | 14.22% |
| ROA (5Y Average) | 6.15% |
| ROIC (5Y Average) | 14.50% |
| Asset Turnover | 0.80x |
| Inventory Turnover | 61.31x |
| Receivables Turnover | 4.64x |
| Cash Conversion Cycle | 58 days |
Taxes
Income tax took 21.35% of pretax income over the last 12 months.
| Income Tax (TTM) | $324.03M |
|---|---|
| Effective Tax Rate | 21.35% |
Scores
DVA has an Altman Z-Score of 1.69, in the distress zone below 1.81, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 1.69 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $14.17B over the last 12 months is up 6.38% from the 12 months before.
| Revenue | $14.17B |
|---|---|
| Revenue Growth (YoY) | +6.38% |
| Gross Profit | $4.57B |
| Operating Income | $2.12B |
| Pretax Income | $1.52B |
| Net Income | $1.22B |
| EBITDA | $2.82B |
| EBIT | $2.12B |
| Reported EPS (TTM) | $14.11 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
| Cash and Equivalents | $495.63M |
|---|---|
| Total Debt | $10.77B |
| Net Debt | $10.27B |
| Net Debt Per Share | $160.94 |
| Working Capital | $1.19B |
| Shareholder Equity | -$591.09M |
| Tangible Book Value | -$8.36B |
| Total Assets | $17.82B |
| Total Liabilities | $16.69B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $576.75M of capital spending, operating cash flow left $1.29B of free cash flow.
| Operating Cash Flow | $1.87B |
|---|---|
| Capital Expenditures | $576.75M |
| Free Cash Flow | $1.29B |
| FCF Per Share | $20.16 |
| Depreciation and Amortization | $697.53M |
| Share Repurchases | $725.34M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 14.97%, against a 5-year average of 14.30%.
| Gross Margin | 32.28% |
|---|---|
| Operating Margin | 14.97% |
| Pretax Margin | 10.71% |
| Net Margin | 8.60% |
| EBITDA Margin | 19.90% |
| EBIT Margin | 14.98% |
| FCF Margin | 9.13% |
| Gross Margin (5Y Average) | 31.46% |
| Operating Margin (5Y Average) | 14.30% |
| Net Margin (5Y Average) | 8.54% |
Growth
Revenue grew 5.53% a year over 3 years, and EPS 22.21% a year.
| Revenue Growth (3Y CAGR) | +5.53% |
|---|---|
| Revenue Growth (5Y CAGR) | +3.39% |
| EPS Growth (3Y CAGR) | +22.21% |
| EPS Growth (5Y CAGR) | +8.42% |
| FCF Growth (3Y CAGR) | +10.89% |
| FCF Growth (5Y CAGR) | +0.09% |
| Operating Income Growth (3Y CAGR) | +15.13% |
Dividends and Yields
DVA does not pay a dividend. Its free cash flow yield is 11.72%.
| Earnings Yield | 8.13% |
|---|---|
| FCF Yield | 11.72% |
| Buyback Yield | 6.28% |
| Shareholder Yield | 10.05% |
Stock Splits
The last split was a 2-for-1 forward split on Sep 9, 2013.
| Last Split Date | Sep 9, 2013 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 2:1 |
Peer Position
Against 12 similar companies, DVA has the 11th highest P/E and the 11th highest P/S.
P/E RatioPeer median 21.7x
P/S RatioPeer median 1.2x
ROICPeer median 11.82%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +8.68%
| P/E Ratio | 12.3x vs 21.7x median |
|---|---|
| P/S Ratio | 0.8x vs 1.2x median |
| ROIC | 16.40% vs 11.82% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +6.38% vs +8.68% median |
Analyst Forecast
Consensus estimates put revenue growth at 3.98% and EPS growth at 24.66% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +3.98% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +24.66% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About DVA
What is DVA's market cap?
DaVita HealthCare Partners has a market cap of $10.96B. Its enterprise value, which adds debt and subtracts cash, is $21.23B.
What is DVA's P/E ratio?
DaVita HealthCare Partners has a trailing P/E ratio of 12.3x and a forward P/E of 11.7x.
How many shares of DVA are outstanding?
DaVita HealthCare Partners has 63.84M shares outstanding. The count is down 11.43% from a year earlier.
Does DVA pay a dividend?
No. DaVita HealthCare Partners does not pay a dividend.
How much debt does DVA have?
DaVita HealthCare Partners has $10.77B of total debt and $495.63M of cash and equivalents, a net debt position of $10.27B.
DVA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors